A study on the effect of phthalate esters and their metabolites on idiopathic infertile males.
Rashmi RanaShikha JoonArun Kumar JainNayan Kumar MohantyPublished in: Andrologia (2020)
Phthalate plasticisers in medical, cosmetic and consumer products might pose serious health implications in humans including infertility. We sought to investigate the correlation, if any, between the phthalates and their metabolites and sperm quality parameters, and male infertility. Phthalate esters (15) and their metabolites (5) were estimated in the blood serum and urine samples from the age-matched 152 infertile and 75 fertile males using gas chromatography (GC) and high-performance liquid chromatography (HPLC). Finally, the data were analysed to correlate phthalate exposure and semen quality parameters in the infertility group. The estimated levels of DEHP, DBP, DIBP, BEHIP, BPBG, DPP, DIOP, DIHP, DMP, DINP, BIOP, DMOP and DICHP were significantly higher in the infertile males compared to the fertile males (p < .05 or p < .01). However, these were not found to be associated with the semen quality parameters (sperm count, motility and sperm morphology). Similarly, HPLC data revealed that the associations between semen parameters (sperm count, sperm motility and sperm morphology) and phthalate metabolite (MEHP and MBP) concentrations in urine samples from the infertile males were mostly unremarkable or statistically nonsignificant. Conclusively, environmental exposure to phthalates and their impacts on male infertility were statistically insignificant in our study groups.
Keyphrases
- polycystic ovary syndrome
- high performance liquid chromatography
- ms ms
- tandem mass spectrometry
- gas chromatography
- mass spectrometry
- solid phase extraction
- simultaneous determination
- healthcare
- insulin resistance
- liquid chromatography
- big data
- high resolution mass spectrometry
- public health
- quality improvement
- type diabetes
- biofilm formation
- electronic health record
- single cell
- adipose tissue
- staphylococcus aureus
- metabolic syndrome
- cystic fibrosis
- mental health
- pseudomonas aeruginosa
- artificial intelligence
- human health
- risk assessment
- climate change